Patent: 10,709,772
✉ Email this page to a colleague
Summary for Patent: 10,709,772
Title: | Use of botulinum neurotoxin in the treatment of sialorrhea |
Abstract: | This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1. |
Inventor(s): | Csikos Janos, Pulte Irena, Althaus Michael, Krüer Markus, Wegener Nico |
Assignee: | Merz Pharma GmbH & Co. KGaA |
Application Number: | US16129311 |
Patent Claims: | see list of patent claims |
Details for Patent 10,709,772
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merz Pharmaceuticals Gmbh C/o Merz Pharmaceuticals Llc | XEOMIN | incobotulinumtoxina | For Injection | 125360 | July 30, 2010 | ⤷ Subscribe | 2038-09-12 |
Merz Pharmaceuticals Gmbh C/o Merz Pharmaceuticals Llc | XEOMIN | incobotulinumtoxina | For Injection | 125360 | November 20, 2015 | ⤷ Subscribe | 2038-09-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |